EVM
NTRP

Eaton Vance Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Eaton Vance Management’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-33,859
Closed -$272K – 1326
2019
Q2 		$272K Hold
33,859
– – ﹤0.01% 1205
2019
Q1 		$185K Sell
33,859
-12,000
-26% -$51.6K ﹤0.01% 1211
2018
Q4 		$164K Buy
+45,859
New +$278K ﹤0.01% 1153

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Eaton Vance Management's NTRP Position: Q3 2019 in Review

Eaton Vance Management sold out of Neurotrope, Inc. Common (NTRP) in Q3 2019, closing a stake of 33,859 shares — an estimated $272K sold.

Eaton Vance Management first reported a position in NTRP in Q4 2018 and held it in 3 quarters. The position peaked at $272K in Q2 2019. 29 funds tracked by Wall St. Rank hold NTRP as of Q3 2019.

  • Eaton Vance Management reported no remaining Neurotrope, Inc. Common position as of Q3 2019 after selling out during the quarter.
  • Eaton Vance Management sold 33,859 Neurotrope, Inc. Common shares in Q3 2019, an estimated $272K.
  • Eaton Vance Management first reported a position in Neurotrope, Inc. Common in Q4 2018 and held it in 3 quarters.
  • Eaton Vance Management's Neurotrope, Inc. Common position peaked at $272K in Q2 2019.
  • 29 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2019.

Based on Eaton Vance Management's 13F filing for Q3 2019, filed 14 Nov 2019.